Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Mar-24 4:16 PM View:  | Valeant Pharmaceuticals Int... (BHC) | 04-Mar-24 | Sale (Planned) | 6,313 | $9.80 | $61,867.40 | (1%) 506.22K to 499.9K | |
| 04-Mar-24 4:16 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Mar-24 | Payment of Exercise | 24,243 | $9.89 | $239,763.00 | (5%) 530.46K to 506.22K | |
| 04-Mar-24 4:16 PM View: | Valeant Pharmaceuticals Int... (BHC) | 29-Feb-24 | Grant | 147,536 | -- | -- | 39% 382.93K to 530.46K | |
| 05-Dec-23 4:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-Dec-23 | Sale (Planned) | 220 | $7.38 | $1,623.60 | (< 1%) 383.14K to 382.93K | |
| 05-Dec-23 4:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Dec-23 | Payment of Exercise | 1,691 | $7.36 | $12,445.80 | (< 1%) 384.84K to 383.14K | |
| 06-Nov-23 5:06 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Nov-23 | Sale (Planned) | 43 | $7.61 | $327.23 | (< 1%) 384.88K to 384.84K | |
| 06-Nov-23 5:06 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Nov-23 | Payment of Exercise | 334 | $7.57 | $2,528.38 | (< 1%) 385.21K to 384.88K | |
| 06-Sep-23 4:33 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Sep-23 | Sale (Planned) | 6,685 | $8.28 | $55,351.80 | (2%) 391.9K to 385.21K | |
| 06-Sep-23 4:33 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-Sep-23 | Payment of Exercise | 51,337 | $8.35 | $428,664.00 | (12%) 443.24K to 391.9K | |
| 06-Mar-23 4:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Mar-23 | Payment of Exercise | 495 | $9.17 | $4,539.15 | (< 1%) 443.73K to 443.24K | |
| 06-Mar-23 4:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-23 | Payment of Exercise | 3,800 | $9.16 | $34,808.00 | (< 1%) 448.31K to 444.51K | |
| 06-Mar-23 4:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-23 | Payment of Exercise | 780 | $9.34 | $7,285.20 | (< 1%) 444.51K to 443.73K | |
| 06-Mar-23 4:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-23 | Grant | 95,119 | -- | -- | 26% 359.19K to 454.3K | |
| 06-Mar-23 4:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-23 | Payment of Exercise | 5,994 | $9.25 | $55,444.50 | (1%) 454.3K to 448.31K | |
| 01-Mar-23 5:45 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Feb-23 | Sale (Planned) | 292 | $9.32 | $2,721.44 | (< 1%) 359.48K to 359.19K | |
| 01-Mar-23 5:45 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-23 | Payment of Exercise | 2,242 | $9.57 | $21,455.90 | (< 1%) 361.72K to 359.48K | |
| 02-Dec-22 4:17 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Dec-22 | Payment of Exercise | 1,691 | $7.70 | $13,020.70 | (< 1%) 363.41K to 361.72K | |
| 04-Nov-22 4:06 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Nov-22 | Payment of Exercise | 334 | $6.45 | $2,154.30 | (< 1%) 363.74K to 363.41K | |
| 07-Sep-22 8:37 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-Sep-22 | Grant | 287,707 | -- | -- | 378% 76.04K to 363.74K | |
| 12-May-22 9:18 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-May-22 | Option Exercise | 7,467 | -- | -- | 11% 68.57K to 76.04K |